Long-lasting Dry Eye Relief

Long-lasting Dry Eye Relief



SYSTANE Family of Products for Dry Eye Management

The All-In-One eye drop that relieves all types of dry eye (aqueous deficient, evaporative and mixed dry) for up to 8 hours

For Moderate dry eye patients. Contains hyaluronic acid providing 2x moisture retention. Supports ocular surface healing in dry eyes, including after eye surgery. 

For mild dry eye patients in need of fast relief.

For severe dry eye patients in need of extra protection.

Removes debris and eye makeup that may cause irritation.


Always read the label and follow the directions for us.


Systane HYDRATION Lubricant Eye Drops combines hyaluronic acid (HA) with hydroxypropyl guar (HP-Guar) to promote greater hydration and lubrication than HA alone.


Hyaluronic Acid

 Upon instillation, HP-Guar cross links with borate, creating a visco-elastic matrix designed to bandage over damaged epithelium and aids in retention of the demulcents. HA has been shown in preclinical studies to potentially promote cellular proliferation, anti-inflammation and wounds healing often required in dry eye management


2x Greater moisture retention versus HA alone*1+

Study overview: Human ocular epithelial cell preparations were cultivated and then soaked in varius test formulations. After rinsing away the formulations and desiccating the cells, moisture retention on the epithelial surface was significantly greater with Systane HYDRATION compare with HA alone (p<0.001)

After rinsing and drying, 44.4% of cells treated with Systane HYDRATION were viable compared to 21.5% of cells treated with HA alone.

Faster ocular re-epithelialistion vs other HA products

Study overview: Epithelium debridement was performed and randomised HA-containing artificial tear products were instilled for a total of 4 administrations. After 24 hours debridement, corneas were stained with flourescein, imaged and analysed to calclate the total flourescein-positive area and evaluate the number of re-epithelialised corneas (flourescein negative) in each treatment group.